Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06628310
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-03
Brief Title:
A Study to Evaluate the Adverse Events Efficacy and Optimal Dose of Intravenous IV ABBV-400 in Combination With IV Fluorouracil Leucovorin and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric Gastroesophageal Junction or Esophageal Adenocarcinoma
Sponsor:
Organization:
None